Patrick Godwin, MD

Department of Medicine, University of Illinois College of Medicine

Disclosure(s): Gilead Sciences, Inc.: Advisor/Consultant, advisory board, speakers bureau

Poster(s):

• (P-1632) Effectiveness of remdesivir in patients with underlying hepatic or renal comorbidity hospitalized for SARS-CoV-2 infection
  Wednesday, October 22, 2025

  12:15 PM - 1:30 PM US ET